|Print Page Close Window|
|CIPHER PHARMACEUTICALS INC filed this Form S-8 POS on 12/21/2016|
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment No. 1 (this “Post-Effective Amendment”) relates to the Registration Statement of Cipher Pharmaceuticals Inc. (the “Company”) on Form S-8 (Registration No. 333-205113), filed with the Securities and Exchange Commission on June 19, 2015 (the “Registration Statement”), which registered the offering of common shares (“Common Shares”), subject to awards of performance share units and restricted share units (collectively with the Common Shares, the “Securities”), under the Performance and Restricted Share Unit Plan.
In accordance with an undertaking made by the Company in the Registration Statement to remove from registration by means of post-effective amendment any Securities which remain unsold at the termination of the offering, the Company hereby amends the Registration Statement to deregister any Securities registered but unsold under the Registration Statement as of the date hereof.